Affimed, a private German-based company specialising in the development of recombinant antibodies, has appointed Volker Lang, as its chief business officer.
Lang joins Affimed from Scil Technology where he was vice president of corporate development. He has broad scientific knowledge and extensive experience in the business development sector will be an asset for Affimed, the company's chief executive officer Rolf H. Guenther, said.
Lang replaces Gavin D Clark who has been working as vice president of business development for the last two years. Lang combines a background as scientist and project manager with extensive experience in the commercialisation of biotechnology products. He has also gained considerable CMC/Production experience in his previous positions.
